Category: New products
-
Liquid Biopsy Tech Adapted for Covid-19 Testing
A company developing non-invasive liquid biopsy tests for cancer received NIH funding to extend that technology for quick Covid-19 virus tests.
-
Moderna to Build mRNA Vaccine Plant in Canada
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada.
-
Gates Grant Funds HIV-Birth Control Implant
A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women.
-
Infographic – Biomedical Innovation Gains Continue
Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
NIH Funds Programmable mRNA to Treat Cancer
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer.
-
Pharma, Biotech Partner on Off-the-Shelf Cell Therapies
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells.
-
Fine-Tuning Process Devised for Gene Therapies
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases.
-
Trial Tests Psychedelic Drug Safety, Chemical Activity
A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders.
-
FDA Clears Stem Cell Trial for Multiple Sclerosis
The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis.